Ionis Pharmaceuticals (IONS) Misses Q4 EPS by $2.72, Revenues Beat; Offers FY21 Revenue Guidance Below Consensus

Go back to Ionis Pharmaceuticals (IONS) Misses Q4 EPS by $2.72, Revenues Beat; Offers FY21 Revenue Guidance Below Consensus
(NASDAQ: IONS) Delayed: 44.44 -2.31 (4.94%)
Previous Close $46.75    52 Week High $62.68 
Open $46.75    52 Week Low $19.59 
Day High $46.75    P/E N/A 
Day Low $44.27    EPS $0.00 
Volume 7,369,252